Evaluation of Auto-EPAP for Management of Upper Airway Obstruction During Non-Invasive Ventilation
Completed · Not applicable · NCT06560411
Conditions: Obstructive Sleep Apnea, Obesity Hypoventilation Syndrome (OHS), Chronic Obstructive Pulmonary Disease (COPD), Neuromuscular Diseases (NMD)
At a glance
- Research payments reported, 2025
- $24,726
- U.S. investigators named
- 5
- Sites paid
- 5
- Planned or actual enrollment
- 23
About the trial
- Sponsor
- Breas Medical, Inc. (with Veranex, Inc.)
- Tested
- Non-Invasive Ventilation (device)
- Dates
- Started 2024-10-03; completion 2025-08-07
- Results posted
- Not yet
To evaluate the safety and effectiveness of the Automatic Expiratory Positive Airway Pressure (Auto-EPAP) feature versus manual expiratory positive airway pressure (EPAP) in the Vivo 45 LS Ventilator.
From ClinicalTrials.gov, last updated 2026-01-28. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Breas Medical, Inc. reported $24,726 in research payments for this study in 2025 (18 payments).
Products named: Vivo 45 Ls
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Ruchir P. Patel, M.D. Sleep Medicine · Scottsdale, AZ
- Jeremy E. Orr, M.D. Critical Care Medicine · San Diego, CA
- Jonathan A. Olin, M.D. Sleep Medicine · Ft Carson, CO
- C G. Petersen, MD Pulmonology · Allentown, PA
- Richard K. Bogan, M.D. Pulmonology · Columbia, SC
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- UC San Diego Health Hillcrest - Hillcrest Med Ctr, CA $12,140
- The Insomnia and Sleep Institute of Arizona LLC $5,980
- Petersen Expert Services PLLC $3,900
- Delta Waves, Inc. $2,508
- Bogan Sleep Consultants $197
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.